AT-076

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

AT-076 is a so-called opioid "pan" antagonist and is the first reasonably balanced antagonist known of all four opioid receptor types. It acts as an antagonist of all four types of opioid receptor, behaving as a competitive antagonist of the μ-opioid receptor (K i = 1.67 nM) and δ-opioid receptor (K i = 19.6 nM) and as a noncompetitive antagonist of the κ-opioid receptor (K i = 1.14 nM) and nociceptin receptor (NOP, K i = 1.75 nM). AT-076 was derived from the κ-opioid receptor antagonist JDTic, which showed affinity for NOP, by removal of two methyl groups from the piperidine ring. This increased affinity for NOP 10-fold relative to the parent compound.

AT-076 is a so-called opioid "pan" antagonist and is the first reasonably balanced antagonist known of all four opioid receptor types. It acts as an antagonist of all four types of opioid receptor, behaving as a competitive antagonist of the μ-opioid receptor (K i = 1.67 nM) and δ-opioid receptor (K i = 19.6 nM) and as a noncompetitive antagonist of the κ-opioid receptor (K i = 1.14 nM) and nociceptin receptor (NOP, K i = 1.75 nM). AT-076 was derived from the κ-opioid receptor antagonist JDTic, which showed affinity for NOP, by removal of two methyl groups from the piperidine ring. This increased affinity for NOP 10-fold relative to the parent compound.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1353127624 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

No external citation was extracted for this revision. That is a statement about the source, not a claim that none exists.